CleanSpace Holdings Ltd (ASX: CSX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CleanSpace Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $36.69 million
P/E Ratio 22.35
Dividend Yield 0.00%
Shares Outstanding 82.18 million
Earnings per share 0.023
Dividend per share N/A
Year To Date Return -31.62%
Earnings Yield 4.48%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

CleanSpace Holdings Ltd (ASX: CSX)
Latest News

asx share price rise represented by man holding bunch of balloons soaring through the air
Share Market News

The Cleanspace (ASX:CSX) share price is soaring 12% higher today. Here's why.

The Cleanspace Holdings Limited (ASX: CSX) share price is storming 12% higher today following a positive business update.

Read more »

Initial Public Offering (IPO)
Share Market News

Here's how Adore Beauty (ASX:ABY) and these new IPOs have fared since listing

Here's how Adore Beauty Group Limited (ASX:ABY) and these IPOs have fared since listing on the Australian share market this…

Read more »

Frequently Asked Questions

No. Cleanspace has not yet paid out any dividends.

Cleanspace listed on 23 October 2020. The Cleanspace share price opened at $7.42 before slumping to its current level.

CSX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About CleanSpace Holdings Ltd

Cleanspace Holdings Ltd (ASX: CSX) designs, manufactures, and sells workplace respiratory protection equipment (RPE) for healthcare and industrial markets. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, masks, filters, and compatible products.

Its respirators are used in industries including mining, welding, stonemasonry, firefighting, construction, and wastewater.  In the healthcare sector, they are used by hospitals, aged care facilities, air rescue, laboratories, first responders, and pharmaceuticals. Cleanspace has clients in more than 36 countries.

CSX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
27 Mar 2026 $0.47 $0.00 0.00% 6,232 $0.47 $0.47 $0.47
25 Mar 2026 $0.47 $0.00 0.00% 17,373 $0.47 $0.47 $0.46
23 Mar 2026 $0.47 $0.00 0.00% 1,279 $0.47 $0.47 $0.47
20 Mar 2026 $0.47 $0.00 0.00% 38,817 $0.47 $0.47 $0.47
19 Mar 2026 $0.47 $0.00 0.00% 2,569 $0.47 $0.47 $0.47
17 Mar 2026 $0.47 $0.00 0.00% 63 $0.47 $0.47 $0.47
16 Mar 2026 $0.47 $-0.01 -2.11% 20,560 $0.49 $0.49 $0.44
13 Mar 2026 $0.48 $-0.03 -5.94% 15,077 $0.52 $0.52 $0.48
11 Mar 2026 $0.51 $-0.02 -3.81% 25,297 $0.51 $0.51 $0.50
10 Mar 2026 $0.53 $-0.02 -3.70% 16,687 $0.54 $0.54 $0.50
09 Mar 2026 $0.54 $0.01 1.89% 15,430 $0.53 $0.54 $0.53
06 Mar 2026 $0.53 $0.03 6.00% 25,217 $0.51 $0.53 $0.50
04 Mar 2026 $0.50 $0.00 0.00% 12,968 $0.50 $0.50 $0.49
03 Mar 2026 $0.50 $-0.02 -3.85% 49,164 $0.51 $0.51 $0.50
02 Mar 2026 $0.52 $-0.05 -8.77% 48,003 $0.53 $0.53 $0.52

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Mar 2026 Graham McLean Exercise 37,500 $20,437
Conversion of securities. 5,25,000 Rights
09 Mar 2026 Graham McLean Buy 59,984 $31,148
On-market trade.
09 Mar 2026 Graham McLean Issued 37,500 $20,437
Conversion of securities.
09 Mar 2026 Graham McLean Expiry 75,000 $40,500
As advised by the company. Lapsed, 562500 RSU

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Dan Kao Director-Operations & FounderExecutive Director Apr 2011
Mr Kao worked in the industrial and healthcare setting for over 20 years, and has experience in manufacturing, supply chain optimisation, quality management systems and in securing patents for innovative technologies.
Ms Lisa Ray Hennessy Non-Executive Director Dec 2021
Ms Hennessy has over 30 years of experience worldwide. She has built a career in Australia including her role as an angel investor and has non executive director experience across listed and private organisations. Prior to this, she spent over a decade in strategy and M&A roles in the US, including Director of Strategy and M&A for Del Monte Foods, Director of M&A at GE Capital, and was also a Consultant at Bain & Company.
Mr Graham McLean Executive DirectorExecutive Chairman Feb 2022
Mr McLean is a experienced senior executive, having worked with NYSE listed Stryker for 16 years, and brings operational and healthcare experience.
Mr Paul Cassano Non-Executive Director Sep 2023
Mr Cassano has over 30 years resources industry experience in senior executive and operations management roles with companies including BHP, Thiess and Downer where he was most recently CEO Mining, successfully leading high performance teams to superior business outcomes and embedding a positive culture. He has both technical and leadership experience and has global and multinational company experience.
Ms Elissa Hansen Company Secretary Nov 2020
-
Ms Gabrielle O'Carroll Chief Executive Officer Jan 2025
-
Gabrielle O'Carroll Chief Executive Officer
-
Bree Greef Chief Financial Officer
-
Elissa Hansen Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
J P Morgan Nominees Australia Pty Limited 11,767,258 15.03%
Acme Co No 7 Pty Ltd <Cvc Emerging Comp Investee> 9,257,535 11.83%
Mutual Trust Pty Ltd 3,788,936 4.84%
Chatswood Wealth Management Pty Ltd 3,227,400 4.12%
Alex Birrell <Baf A/C> 2,798,962 3.58%
HSBC Custody Nominees (Australia) Limited 2,583,619 3.30%
Dan Kao 2,530,000 3.23%
Min Fang 2,057,248 2.63%
Acorn Capital Private Opportunities Fund L P 1,670,391 2.13%
Est Mr Alfred Harry Hugh Myers <LucyS A/C> 1,449,481 1.85%
Miss Linda Ying Wang <Kao And Wang Family A/C> 1,402,816 1.79%
UBS Nominees Pty Ltd 1,391,043 1.78%
BNP Paribas Noms (Nz) Ltd 1,346,778 1.72%
Columbus Investment Services Ltd <Kelly Partners 2 A/C> 1,191,542 1.52%
Mr Ching-Ming Liu 994,842 1.27%
Garrett Smythe Ltd 885,321 1.13%
Jenny Hsu 815,734 1.04%
Mr Sundeep Kalra & Mr Anoop Kalra & Mrs Shikha Mohanty <Ganesh Super Fund A/C> 793,544 1.01%
Mr Joe Ching Wei Kao 782,484 1.00%
Ms Carrie Jane Waring 728,731 0.95%

Profile

since

Note